高级检索
当前位置: 首页 > 详情页

Exploring the mechanism of fibrates regulating HIF-1A in the treatment of ischemic stroke based on network pharmacology and molecular docking

文献详情

资源类型:
Pubmed体系:
机构: [1]College of Clinical Medicine, Dali University, Dali, 671000, Yunnan, People's Republic of China. [2]College of Pharmacy, Dali University, Dali, 671000, Yunnan, People's Republic of China. [3]Department of Pharmacy, The First Affiliated Hospital of Dali University, Dali, 671000, Yunnan, People's Republic of China. [4]Department of Geriatrics, South District of Hefei First People's Hospital, Hefei, 230000, Anhui, People's Republic of China. [5]Department of Pharmacy, The People's Hospital of Baoshan, Baoshan, 678000, Yunnan, People's Republic of China.
出处:

关键词: Fibrates IS HIF1A Network pharmacology Molecular docking

摘要:
Fibrates can prevent and treat ischemic stroke (IS), the occurrence and development of IS is closely related to hypoxia-inducible factor-1A (HIF-1A). However, the exact mechanism by which fibrates regulate HIF-1A to treat IS remains unclear. So network pharmacology and molecular docking were used to explore the mechanism by which fibrates regulate HIF-1A to treat IS, firstly, the structure of five fibrates were obtained by reviewing the literature and pharmacopoeia, then the potential targets of fibrates, IS, HIF1A and HIF1A-related genes were obtained through various databases, their common targets were obtained through Venny 2.1.0. The PPI network diagram of fibrates, IS and HIF1A-related genes was plotted by String and Cytoscape3.8.1. The GO functional analysis results and KEGG pathways of fibrates, IS, HIF1A and HIF1A related genes were obtained by Metascape. Finally, the molecular docking of fibrates and HIF1A was performed by AutoDock. The common targets of five fibrates and IS showed that only 3 fibrates contained HIF1A, GO functional analysis, KEGG pathway analysis and molecular docking showed that fibrates can better regulate HIF1A to treat IS, its main action pathways are pathways in cancer, lipid and atherosclerosis and HIF-1 signaling pathway.© 2024. The Author(s).

基金:
语种:
PubmedID:
第一作者:
第一作者机构: [1]College of Clinical Medicine, Dali University, Dali, 671000, Yunnan, People's Republic of China. [5]Department of Pharmacy, The People's Hospital of Baoshan, Baoshan, 678000, Yunnan, People's Republic of China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:84979 今日访问量:0 总访问量:692 更新日期:2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号